|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM191659800 |
003 |
DE-627 |
005 |
20231223191620.0 |
007 |
cr uuu---uuuuu |
008 |
231223s2009 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/j.clim.2009.08.008
|2 doi
|
028 |
5 |
2 |
|a pubmed24n0639.xml
|
035 |
|
|
|a (DE-627)NLM191659800
|
035 |
|
|
|a (NLM)19786367
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Wahlström, Jan
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Autoimmune T cell responses to antigenic peptides presented by bronchoalveolar lavage cell HLA-DR molecules in sarcoidosis
|
264 |
|
1 |
|c 2009
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 22.12.2009
|
500 |
|
|
|a Date Revised 17.11.2011
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a The etiology of sarcoidosis remains unknown. Recently, by mass spectrometric sequencing of peptides eluted from HLA-DR molecules of bronchoalveolar lavage (BAL) cells from DRB10301(pos) patients, we identified potential self-antigens in sarcoidosis. The aim of the present study was to investigate the capacity of selected peptides to stimulate lung and blood T cells of sarcoidosis patients using an interferon-gamma ELISPOT assay. In peripheral blood, there were strong T cell responses to a peptide derived from the cytoskeletal protein vimentin in 6 out of 11 DRB10301(pos) patients with active disease but not in patients with other HLA types. BAL T cell responses against peptides derived from ATP synthase or from lysyl-tRNA synthetase were detected in DRB10301(pos) as well as DRB10301(neg) patients. By using antigenic peptides presented in vivo in the lungs of sarcoidosis patients, we have identified blood and lung T cell autoimmune responses that may help sustain the inflammation in this disease
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Research Support, N.I.H., Extramural
|
650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
650 |
|
7 |
|a Autoantibodies
|2 NLM
|
650 |
|
7 |
|a HLA-DR Antigens
|2 NLM
|
650 |
|
7 |
|a HLA-DRB1 Chains
|2 NLM
|
650 |
|
7 |
|a Peptide Fragments
|2 NLM
|
650 |
|
7 |
|a Vimentin
|2 NLM
|
650 |
|
7 |
|a DNA
|2 NLM
|
650 |
|
7 |
|a 9007-49-2
|2 NLM
|
650 |
|
7 |
|a Amino Acyl-tRNA Synthetases
|2 NLM
|
650 |
|
7 |
|a EC 6.1.1.-
|2 NLM
|
700 |
1 |
|
|a Dengjel, Jörn
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Winqvist, Ola
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Targoff, Ira
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Persson, Bengt
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Duyar, Hüseyin
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Rammensee, Hans-Georg
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Eklund, Anders
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Weissert, Robert
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Grunewald, Johan
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 133(2009), 3 vom: 01. Dez., Seite 353-63
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
773 |
1 |
8 |
|g volume:133
|g year:2009
|g number:3
|g day:01
|g month:12
|g pages:353-63
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2009.08.008
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 133
|j 2009
|e 3
|b 01
|c 12
|h 353-63
|